The influence of breathing pattern during nebulization on the delivery of arformoterol using a breath simulator

Respiratory Care

Volumn 54, Issue 11, 2009, Pages 1488-1492

  Bauer, Andrea ^a   McGlynn, Paul ^a   Bovet, Li Li ^b   Mims, Pamela L ^b   Curry, Lisa A ^a   Hanrahan, John P ^c  

^a Sepracor   (United States)

^b Cirrus Pharmaceuticals   (United States)

^c PULMATRIX INC   (United States)

Author keywords

Aerosol; Arformoterol; Breath simulation; Emitted dose; Nebulizer

Indexed keywords

ARFORMOTEROL;

AEROSOL; ARTICLE; BREATHING PATTERN; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER SIMULATION; CONTROLLED STUDY; DRUG DETERMINATION; EXPIRED AIR; FILTER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INHALATION; MEDICAL NEBULIZER; NEBULIZATION; SIMULATOR;

BRONCHODILATOR AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHANOLAMINES; HUMANS; MODELS, BIOLOGICAL; NEBULIZERS AND VAPORIZERS; RESPIRATION;

EID: 70849117729     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, Smaldone GC, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/ American College of Asthma, Allergy, and Immunology. Chest 2005;127(1):335-371. (Pubitemid 41724594)
2. Smaldone GC, Cruz-Rivera M, Nikander K. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J Aerosol Med 1998;11(2):113-125.
3. Dennis JH. A review of issues relating to nebulizer standards. J Aerosol Med 1998;11(Suppl 1):S73-S79.
4. Bosco AP, Rhem RG, Dolovich MB. In vitro estimations of in vivo jet nebulizer efficiency using actual and simulated tidal breathing patterns. J Aerosol Med 2005;18(4):427-438.
5. Roth AP, Lange CF, Finlay WH. The effect of breathing pattern on nebulizer drug delivery. J Aerosol Med 2003;16(3):325-339.
6. Nikander K, Denyer J, Everard M, Smaldone GC. Validation of a new breathing simulator generating and measuring inhaled aerosol with adult breathing patterns. J Aerosol Med 2000;13(2):139-146.
7. Smaldone GC. Drug delivery via aerosol systems: concept of "aerosol inhaled". J Aerosol Med 1991;4(3):229-235.
8. Smaldone GC, Fuhrer J, Steigbigel RT, McPeck M. Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1991;143(4 Pt 1):727-737.
9. Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP. Nebulized arformoterol in patients with COPD: a 12- week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial. Clin Ther 2007;29(2):261-278. (Pubitemid 46671382)
10. Hanrahan J, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Baumgartner RA. Effect of nebulized arformoterol on airway function in COPD: results from 2 randomized trials. COPD 2008;5(1):25-34.
11. Coates AL, MacNeish CF, Lands LC, Meisner D, Kelemen S, Vadas EB. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers. Chest 1998;113(4):951-956. (Pubitemid 28216437)
12. Barry PW and O'Callaghan C. Drug output from nebulizers is dependent on the method of measurement. Eur Respir J 1998;12(2): 463-466. (Pubitemid 28389546)
13. Knoch M, Wunderlich E, Geldner S. A nebulizer system for highly reproducible aerosol delivery. J Aerosol Med 1994;7(3):229-237.
14. Nikander K. Drug delivery systems. J Aerosol Med 1994;7(Suppl 1):S19-S24.
15. Nikander K, Denyer J, Smith N, Wollmer P. Breathing patterns and aerosol delivery: impact of regular human patterns, and sine and square waveforms on rate of delivery. J Aerosol Med 2001;14(3): 327-333.
16. Smaldone GC. Drug delivery by nebulization: "reality testing". J Aerosol Med 1994;7(3):213-216.
17. Smaldone GC. Advances in aerosols: adult respiratory disease. J Aerosol Med 2006;19(1):36-46.
18. Coates AL, MacNeish CF, Allen PD, Ho SL, Lands LC. Do sinusoidal models of respiration accurately reflect the respiratory events of patients breathing on nebulizers? J Aerosol Med 1999;12(4):265-273.
19. O'Callaghan C, White J, Jackson J, Crosby D, Dougill B, Bland H. The effects of Heliox on the output and particle-size distribution of salbutamol using jet and vibrating mesh nebulizers. J Aerosol Med 2007;20(4):434-444.
20. Hess DR. Nebulizers: principles and performance. Respir Care 2000; 45(6):609-622.
21. Barry PW and O'Callaghan C. An in vitro analysis of the output of budesonide from different nebulizers. J Allergy Clin Immunol 1999; 104(6):1168-1173. (Pubitemid 30004975)
22. Rau JL, Ari A, Restrepo RD. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir Care 2004;49(2):174-179.
23. Nagel MW, Doyle CC, Bates SL, Mitchell JP. An in vitro investigation of common nebulizer dosing protocols, comparing a breath-actuated with conventional pneumatic small-volume nebulizer (SVN). Raleigh, NC: Davis Horwood International; 2002:627-629.